Oppenheimer Asset Management Inc. Abbott Laboratories Transaction History

Oppenheimer Asset Management Inc.

$8.04 Billion
Q3 2024

A detailed history of Oppenheimer Asset Management Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 252,472 shares of ABT stock, worth $29.3 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

252,472

Previous 259,792 2.82%

Holding current value

$29.3 Million

Previous $27 Million 6.63%

% of portfolio

0.36%

Previous 0.35%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$100.07 - $118.13 $732,512 - $864,711	-7,320 Reduced 2.82%	252,472 $28.8 Million
Q2 2024 Aug 08, 2024	BUY	$100.73 - $112.44 $2.91 Million - $3.25 Million	28,926 Added 12.53%	259,792 $27 Million
Q1 2024 May 06, 2024	BUY	$109.52 - $120.96 $2.69 Million - $2.97 Million	24,580 Added 11.92%	230,866 $26.2 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $637,282 - $780,086	7,066 Added 3.55%	206,286 $22.7 Million
Q3 2023 Nov 07, 2023	SELL	$95.53 - $114.62 $4.56 Million - $5.47 Million	-47,694 Reduced 19.32%	199,220 $19.3 Million
Q2 2023 Aug 02, 2023	SELL	$100.78 - $112.29 $792,937 - $883,497	-7,868 Reduced 3.09%	246,914 $26.9 Million
Q1 2023 May 10, 2023	SELL	$96.86 - $114.01 $1.22 Million - $1.44 Million	-12,616 Reduced 4.72%	254,782 $25.8 Million
Q4 2022 Feb 06, 2023	SELL	$95.06 - $111.52 $478,056 - $560,834	-5,029 Reduced 1.85%	267,398 $29.4 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $847,230 - $980,934	-8,756 Reduced 3.11%	272,427 $26.4 Million
Q2 2022 Aug 08, 2022	SELL	$102.07 - $123.37 $8.42 Million - $10.2 Million	-82,540 Reduced 22.69%	281,183 $30.6 Million
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $1.18 Million - $1.44 Million	-10,373 Reduced 2.77%	363,723 $43.1 Million
Q4 2021 Feb 02, 2022	BUY	$115.53 - $141.46 $127,429 - $156,030	1,103 Added 0.3%	374,096 $52.7 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $1.12 Million - $1.23 Million	-9,562 Reduced 2.5%	372,993 $44.1 Million
Q2 2021 Aug 03, 2021	SELL	$105.79 - $124.53 $965,862 - $1.14 Million	-9,130 Reduced 2.33%	382,555 $44.4 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $1.69 Million - $2 Million	-15,565 Reduced 3.82%	391,685 $46.9 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $2.42 Million - $2.63 Million	23,001 Added 5.99%	407,250 $44.6 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $311,576 - $378,386	3,400 Added 0.89%	384,249 $41.8 Million
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $1.62 Million - $2.07 Million	21,152 Added 5.88%	380,849 $34.8 Million
Q1 2020 May 08, 2020	BUY	$62.82 - $91.86 $13 Million - $18.9 Million	206,211 Added 134.35%	359,697 $28.4 Million
Q4 2019 Feb 07, 2020	SELL	$78.51 - $87.4 $112,818 - $125,593	-1,437 Reduced 0.93%	153,486 $13.3 Million
Q3 2019 Oct 31, 2019	SELL	$81.84 - $88.74 $707,179 - $766,802	-8,641 Reduced 5.28%	154,923 $13 Million
Q2 2019 Aug 09, 2019	SELL	$72.88 - $85.0 $9.94 Million - $11.6 Million	-136,369 Reduced 45.47%	163,564 $13.8 Million
Q1 2019 Apr 24, 2019	SELL	$66.22 - $80.06 $4.55 Million - $5.51 Million	-68,779 Reduced 18.65%	299,933 $24 Million
Q4 2018 Jan 30, 2019	BUY	$65.56 - $74.27 $1.87 Million - $2.12 Million	28,545 Added 8.39%	368,712 $26.7 Million
Q3 2018 Oct 26, 2018	SELL	$60.81 - $73.36 $438,136 - $528,558	-7,205 Reduced 2.07%	340,167 $25 Million
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $1.85 Million - $2.04 Million	-32,051 Reduced 8.45%	347,372 $21.2 Million
Q1 2018 May 09, 2018	BUY	$56.27 - $63.62 $586,052 - $662,602	10,415 Added 2.82%	379,423 $22.7 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $17.7 Million - $19.8 Million	369,008	369,008 $19.7 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account

Oppenheimer Asset Management Inc. Abbott Laboratories Transaction History